OTC: PPCB - Propanc Biopharma, Inc.

Altı ay boyunca karlılık: -63.64%
Sektör: Healthcare

Promosyon programı Propanc Biopharma, Inc.


Şirket hakkında

Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes.

Daha fazla ayrıntı
The company has a research collaboration with University of Jaén that undertakes the research activities for POP1 joint drug discovery program; and a joint research and drug discovery program with Universities of Jaén and Granada to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.

EBITDA -0.0026
EV/EBITDA -0.6557
ISIN US74346N4043
Industry Biotechnology
P/BV -0.0014
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.propanc.com
Цена ао 0.0027
Число акций ао 0.0017388 млрд
Günlük fiyat değişimi: 0% (0.0004)
Haftalık fiyat değişimi: 0% (0.0004)
Aylık fiyat değişimi: 0% (0.0004)
3 ayda fiyat değişimi: -55.56% (0.0009)
Altı ayda fiyat değişimi: -63.64% (0.0011)
Yıllık fiyat değişimi: -97.95% (0.0195)
3 yılda fiyat değişimi: -98.69% (0.0306)
5 yılda fiyat değişimi: -99.96% (0.93)
Yılbaşından bu yana fiyat değişimi: -96.33% (0.0109)

Hafife alma

İsim Anlam Seviye
P/S 0 0
P/BV -0.0753 0
P/E 0 0
EV/EBITDA -0.4394 0
Toplam: 2.5

Yeterlik

İsim Anlam Seviye
ROA, % -4410.17 0
ROE, % 85.35 10
Toplam: 3.33

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.3113 10
Toplam: 6

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 0 0
karlılık Ebitda, % -61.88 0
karlılık EPS, % -99.97 0
Toplam: 0



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. James Nathanielsz Executive Chairman, CEO, CFO, Treasurer & Secretary 430.28k 1974 (50 yıllar)
Dr. Julian Norman Kenyon ChB, M.D., MB Chief Scientific Officer, CTO & Director 35.99k 1948 (76 yıllar)
Prof. Klaus Kutz Chief Medical Officer & Member of Scientific Advisory Board 18.23k

Adres: Australia, Camberwell. VIC, 302. 6 Butler Street - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.propanc.com